{"id":"https://openalex.org/W2008914547","doi":"https://doi.org/10.1111/j.1365-2710.2007.00812.x","title":"Inherited long QT syndrome revealed by antifungals drug?drug interaction","display_name":"Inherited long QT syndrome revealed by antifungals drug?drug interaction","publication_year":2007,"publication_date":"2007-05-09","ids":{"openalex":"https://openalex.org/W2008914547","doi":"https://doi.org/10.1111/j.1365-2710.2007.00812.x","mag":"2008914547","pmid":"https://pubmed.ncbi.nlm.nih.gov/17489884"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2710.2007.00812.x","doi":"https://doi.org/10.1111/j.1365-2710.2007.00812.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2710.2007.00812.x","pdf_url":null,"source":{"id":"https://openalex.org/S156693432","display_name":"Journal of Clinical Pharmacy and Therapeutics","issn_l":"0269-4727","issn":["0269-4727","1365-2710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Pharmacy and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034982542","display_name":"C\u00e9line Eiden","orcid":"https://orcid.org/0000-0002-7839-9811","observed_orcids":["https://orcid.org/0000-0002-7839-9811"]},"institutions":[{"id":"https://openalex.org/I4210132125","display_name":"H\u00f4pital Lapeyronie","ror":"https://ror.org/03xzagw65","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210132125"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Eiden","raw_affiliation_strings":["Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210132125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020786003","display_name":"H\u00e9l\u00e8ne Peyri\u00e8re","orcid":"https://orcid.org/0000-0003-4735-9099","observed_orcids":["https://orcid.org/0000-0003-4735-9099"]},"institutions":[{"id":"https://openalex.org/I4210132125","display_name":"H\u00f4pital Lapeyronie","ror":"https://ror.org/03xzagw65","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210132125"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H. Peyri\u00e8re","raw_affiliation_strings":["Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210132125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030656467","display_name":"R. Tichit","orcid":"https://orcid.org/0000-0002-3904-361X","observed_orcids":["https://orcid.org/0000-0002-3904-361X"]},"institutions":[{"id":"https://openalex.org/I4210147545","display_name":"H\u00f4pital Arnaud de Villeneuve","ror":"https://ror.org/04m6sq715","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210147545"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"R. Tichit","raw_affiliation_strings":["Department of Pediatric Oncology, Arnaud de Villeneuve Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Arnaud de Villeneuve Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210147545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012040215","display_name":"M. Cociglio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132125","display_name":"H\u00f4pital Lapeyronie","ror":"https://ror.org/03xzagw65","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210132125"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Cociglio","raw_affiliation_strings":["Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210132125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073005901","display_name":"Pascal Am\u00e9dro","orcid":"https://orcid.org/0000-0003-3649-0294","observed_orcids":["https://orcid.org/0000-0003-3649-0294"]},"institutions":[{"id":"https://openalex.org/I4210147545","display_name":"H\u00f4pital Arnaud de Villeneuve","ror":"https://ror.org/04m6sq715","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210147545"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Amedro","raw_affiliation_strings":["Department of Pediatric Cardiology, Arnaud de Villeneuve Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Cardiology, Arnaud de Villeneuve Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210147545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112137949","display_name":"Jean\u2010Pierre Blayac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132125","display_name":"H\u00f4pital Lapeyronie","ror":"https://ror.org/03xzagw65","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210132125"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.-P. Blayac","raw_affiliation_strings":["Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210132125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042950802","display_name":"Genevi\u00e8ve Margueritte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147545","display_name":"H\u00f4pital Arnaud de Villeneuve","ror":"https://ror.org/04m6sq715","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210147545"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Margueritte","raw_affiliation_strings":["Department of Pediatric Oncology, Arnaud de Villeneuve Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Arnaud de Villeneuve Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210147545"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5106419581","display_name":"Dominique Hillaire\u2010Buys","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132125","display_name":"H\u00f4pital Lapeyronie","ror":"https://ror.org/03xzagw65","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292","https://openalex.org/I4210132125"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Hillaire-Buys","raw_affiliation_strings":["Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology and Toxicology, Lapeyronie Hospital, Montpellier, France","institution_ids":["https://openalex.org/I4210132125"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2700,"currency":"USD","value_usd":2700},"apc_paid":null,"fwci":1.7854,"has_fulltext":false,"cited_by_count":30,"citation_normalized_percentile":{"value":0.86116197,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"32","issue":"3","first_page":"321","last_page":"324"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.8779000043869019,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.8779000043869019,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.09790000319480896,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/long-qt-syndrome","display_name":"long QT syndrome","score":0.8650000095367432},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8320000171661377},{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":0.828000009059906},{"id":"https://openalex.org/keywords/caspofungin","display_name":"caspofungin","score":0.9210000038146973},{"id":"https://openalex.org/keywords/posaconazole","display_name":"posaconazole","score":0.9829999804496765},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.8529999852180481},{"id":"https://openalex.org/keywords/torsades-de-pointes","display_name":"torsades de pointes","score":0.8930000066757202},{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.8379999995231628},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8289999961853027},{"id":"https://openalex.org/keywords/mucormycosis","display_name":"mucormycosis","score":0.9399999976158142},{"id":"https://openalex.org/keywords/cyp2c9","display_name":"CYP2C9","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.9990000128746033},{"id":"https://openalex.org/keywords/extensive-metabolizers","display_name":"extensive metabolizers","score":0.7580000162124634},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.9335768222808838},{"id":"https://openalex.org/C2778566413","wikidata":"https://www.wikidata.org/wiki/Q906453","display_name":"Posaconazole","level":4,"score":0.9031600952148438},{"id":"https://openalex.org/C2780486423","wikidata":"https://www.wikidata.org/wiki/Q1625433","display_name":"Torsades de pointes","level":3,"score":0.8664352893829346},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.8419082164764404},{"id":"https://openalex.org/C2780402444","wikidata":"https://www.wikidata.org/wiki/Q420875","display_name":"Caspofungin","level":4,"score":0.749245285987854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7443940043449402},{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.5186723470687866},{"id":"https://openalex.org/C2779703243","wikidata":"https://www.wikidata.org/wiki/Q653924","display_name":"Long QT syndrome","level":3,"score":0.5126528143882751},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4364829659461975},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.43428391218185425},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43082094192504883},{"id":"https://openalex.org/C2779578097","wikidata":"https://www.wikidata.org/wiki/Q1484058","display_name":"Short QT syndrome","level":4,"score":0.4113805890083313},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40138715505599976},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3563504219055176},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.2062332034111023},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.10866707563400269},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.08121097087860107},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009091","descriptor_name":"Mucormycosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009091","descriptor_name":"Mucormycosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016171","descriptor_name":"Torsades de Pointes","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D016171","descriptor_name":"Torsades de Pointes","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2710.2007.00812.x","doi":"https://doi.org/10.1111/j.1365-2710.2007.00812.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2710.2007.00812.x","pdf_url":null,"source":{"id":"https://openalex.org/S156693432","display_name":"Journal of Clinical Pharmacy and Therapeutics","issn_l":"0269-4727","issn":["0269-4727","1365-2710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Pharmacy and Therapeutics","raw_type":"journal-article"},{"id":"pmid:17489884","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17489884","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacy and therapeutics","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W157973430","https://openalex.org/W1066949424","https://openalex.org/W1890388819","https://openalex.org/W1983814039","https://openalex.org/W1995236993","https://openalex.org/W2027820553","https://openalex.org/W2058668950","https://openalex.org/W2067978628","https://openalex.org/W2073064750","https://openalex.org/W2076522986","https://openalex.org/W2105376278","https://openalex.org/W2131842719","https://openalex.org/W2165295633","https://openalex.org/W4236014310"],"related_works":["https://openalex.org/W2079778741","https://openalex.org/W2149978174","https://openalex.org/W3165530467","https://openalex.org/W2017165617","https://openalex.org/W1983543464","https://openalex.org/W1985323718","https://openalex.org/W2896094597","https://openalex.org/W2122960122","https://openalex.org/W2165295633","https://openalex.org/W7100100681"],"abstract_inverted_index":{"A":[0],"14-year-old":[1],"Tahitian":[2],"girl":[3],"with":[4,15,37,41,71,82],"acute":[5],"myeloid":[6],"leukaemia":[7],"and":[8,18,45,75,85,94],"a":[9],"suspected":[10],"mucormucosis":[11],"infection":[12],"was":[13,27,59,67],"treated":[14],"intravenous":[16],"voriconazole":[17,26],"caspofungin.":[19],"Because":[20],"of":[21,23,79,97],"worsening":[22],"fungal":[24],"infection,":[25],"switched":[28],"to":[29,73,90],"posaconazole.":[30],"During":[31],"the":[32,34,56,65,95],"switch,":[33],"patient":[35,66],"presented":[36],"QT":[38,99],"interval":[39],"prolongation":[40],"'torsades":[42],"de":[43,92],"pointes'":[44],"reversible":[46],"cardiac":[47],"arrest.":[48],"Voriconazole":[49],"plasma":[50],"level":[51],"measured":[52],"15":[53],"h":[54],"after":[55],"last":[57],"administration":[58],"7":[60],"mg/L.":[61],"Genotyping":[62],"suggested":[63],"that":[64],"an":[68],"extensive":[69],"metabolizer":[70],"respect":[72],"CYP2C9":[74],"CYP2C19.":[76],"The":[77],"association":[78],"antifungal":[80],"agents":[81],"pro-arrhythmogenic":[83],"drugs":[84],"other":[86],"risk":[87],"factors":[88],"led":[89],"torsades":[91],"pointes":[93],"revealing":[96],"inherited":[98],"syndrome.":[100]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}